Piperacillin-tazobactam use in ESBL Escherichia coli bacteremia: Should reporting be revised?

Samuel de l’Étoile-Morel, Matthew P. Cheng, Alexander Pellan Cheng, Emily G. McDonald and Todd C. Lee

Article (2018)

Open Acess document at official publisher

An external link is available for this item

Department:	Institut de génie biomédical
PolyPublie URL:	https://publications.polymtl.ca/61482/
Journal Title:	Journal of the Association of Medical Microbiology and Infectious Disease Canada (vol. 3, no. 1)
Publisher:	University of Toronto Press
DOI:	10.3138/jammi.3.1.05
Official URL:	https://doi.org/10.3138/jammi.3.1.05
Date Deposited:	18 Dec 2024 14:31
Last Modified:	18 Dec 2024 14:31

Cite in APA 7:	de l’Étoile-Morel, S., Cheng, M. P., Cheng, A. P., McDonald, E. G., & Lee, T. C. (2018). Piperacillin-tazobactam use in ESBL Escherichia coli bacteremia: Should reporting be revised? Journal of the Association of Medical Microbiology and Infectious Disease Canada, 3(1), 24-29. https://doi.org/10.3138/jammi.3.1.05
APA 7 (HTML)ASCII CitationAtomBibTeXDOIsDublin CoreEndNote (.ENW)MARC (ISO 2709/UTF-8) (.MRC)MARC (UTF-8) (.MRK8)MARC XMLMPEG-21 DIDLMultiline CSVOAI-ORE Resource Map (Atom Format)OPENAIREOpenURL ContextObjectOpenURL ContextObject in SpanRDF+N-TriplesRDF+N3RDF+XMLReferReference Manager (.RIS)Simple Metadata

Statistics

Repository Staff Only